未登录

S

Sandrine Georgeon

swiss federal institutes of technology domain

H指数:21

被引数:2,163

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drug-controlled CAR T cells through the regulation of cell-cell interactions

通过细胞-细胞相互作用调控的药物控制CAR T细胞

Nature Chemical Biology

IF13.7

2026-02-010

OA

Accurate single-domain scaffolding of three nonoverlapping protein epitopes using deep learning

利用深度学习对三个非重叠蛋白质表位进行精确的单域支架构建

Nature Chemical Biology

IF13.7

2025-12-050

OAAI

One-shot design of functional protein binders with BindCraft

使用BindCraft进行功能性蛋白质结合物的一体化设计

IF48.5

2025-08-270

OAAI

Martin Pacesa; Lennart Nickel; Christian Schellhaas; Joseph Schmidt; Ekaterina Pyatova; Lucas Kissling; Patrick Barendse; Jagrity Choudhury; Srajan Kapoor; Ana Alcaraz-Serna; Yehlin Cho; Kourosh H. Ghamary; Laura Vinué; Brahm J. Yachnin; Andrew M. Wollacott; Stephen Buckley; Adrie H. Westphal; Simon Lindhoud; Sandrine Georgeon; Casper A. Goverde; Georgios N. Hatzopoulos; Pierre Gönczy; Yannick D. Muller; Gerald Schwank; Daan C. Swarts; Alex J. Vecchio; Bernard L. Schneider; Sergey Ovchinnikov; Bruno E. Correia

Dual ON/OFF- switch chimeric antigen receptor controlled by two clinically approved drugs

由两种临床批准的药物控制的双开关嵌合抗原受体

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-10-250

OAAI

Exploring dark-matterprotein folds using deep learning

探索暗物质蛋白折叠结构利用深度学习

IF7.7

2024-10-011

OAAI

Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

NATURE CHEMICAL BIOLOGY

IF13.7

2024-05-291

PRE

Rational Design of Chemically Controlled Antibodies and Protein Therapeutics

ACS CHEMICAL BIOLOGY

IF3.8

2023-05-308

OAAI

A rational blueprint for the design of chemically-controlled protein switches

NATURE COMMUNICATIONS

IF15.7

2021-10-0120

OAAI

Bottom-up de novo design of functional proteins with complex structural features

NATURE CHEMICAL BIOLOGY

IF13.7

2021-01-0473

PREAI

Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms

NATURE COMMUNICATIONS

IF15.7

2020-05-0821

OAAI

Computational design of anti-CRISPR proteins with improved inhibition potency

具有改进抑制效力的抗CRISPR蛋白的计算设计

NATURE CHEMICAL BIOLOGY

IF13.7

2020-04-1317

OAAI

Rapid Screen for Tyrosine Kinase Inhibitor Resistance Mutations and Substrate Specificity

ACS CHEMICAL BIOLOGY

IF3.8

2019-07-249

PREAI

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase

NATURE COMMUNICATIONS

IF15.7

2017-12-1336

OAAI

Single-molecule kinetic analysis of HP1-chromatin binding reveals a dynamic network of histone modification and DNA interactions

NUCLEIC ACIDS RESEARCH

IF13.1

2017-08-0349

OAAI

Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics

IF13.4

2017-01-2381

OAAI

Kinase-templated abiotic reaction

CHEMICAL SCIENCE

IF7.4

2017-01-0114

OAAI

Iron bioavailability from fresh cheese fortified with iron-enriched yeast

EUROPEAN JOURNAL OF NUTRITION

IF4.3

2016-03-3016

PREAI

The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility

NATURE COMMUNICATIONS

IF15.7

2014-11-1740

OAAI

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

HUMAN MOLECULAR GENETICS

IF3.2

2014-01-09197

OA

Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains

使用针对SHP2 SH2结构域的高度特异性单体抑制剂解剖bcr-abl信号网络

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2013-08-26107

OAAI